Treatment options for PDE6B-related RP are currently not available; however, proof-of-concept studies with sub-retinal gene therapy showed positive effects in mice and dogs when treated at a very early time during postnatal development of the retina [17, 18]. Here, PDE6B is linked to retinitis pigmentosa 1.